The platform Regeneron co-founder George Yancopoulos helped build yielded the first successful Ebola drug. Now, they face an even bigger test in Covid-19. (Regeneron)
With all eyes on their Covid-19 drug, Regeneron wins a landmark approval in Ebola
For the first time, the FDA has approved a therapy for Ebola, handing a landmark OK to Regeneron at the same moment that the New …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
